Safety and clinical activity of ruxolitinib combined with carfilzomib and dexamethasone for patients with carfilzomib-refractory multiple myeloma: results from a phase 1 clinical trial Meeting Abstract
| Authors: | Atrash, S.; Symanowski, J.; Norek, S.; Begic, X.; Bhutani, M.; Paul, B.; Varga, C.; Kin, A.; Voorhees, J. P.; Usmani, S. |
| Abstract Title: | Safety and clinical activity of ruxolitinib combined with carfilzomib and dexamethasone for patients with carfilzomib-refractory multiple myeloma: results from a phase 1 clinical trial |
| Meeting Title: | 20th Annual Meeting and Exposition of the International Myeloma Society |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 23 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Sep 27-30 |
| Meeting Location: | Athens, Greece |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S160 |
| Language: | English |
| ACCESSION: | WOS:001079705400279 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(23)01845-1 |
| Notes: | Meeting Abstract: P-227 -- Source: Wos |
